Comparison of Sugammadex and Sugammadex-neostigmine Combination in the Antagonism of Moderate Neuromuscular Block
Clinical trial NCT05228223 · UNKNOWN
Trial details
- NCT number
- NCT05228223
- Sponsor
- Ankara City Hospital Bilkent
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-01
- Primary completion
- 2022-05-01
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.